Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Independent Impact of hsCRP on Cardiovascular Risk
Multivariate adjusted relative risks of future cardiovascular events according to baseline levels of high-sensitivity C-reactive protein (hsCRP) <1 mg/l, 1 to 3 mg/l, and >3 mg/l in 14 major prospective cohort studies. Data adapted from references 1,11–13,16–20,22,23,51–54. ARIC = Atherosclerosis Risk in Communities study; CHS = Cardiovascular Health Study; EPIC = Evaluation for Prevention of Ischemic Complications-Norfolk study; FHS = Framingham Heart Study; HPFUS = Health Professionals Follow-Up Study; Iceland = Reykjavik Heart Study data; Kuopio = Kuopio Heart Study; MONICA = Monitoring Trends and Development in Cardiovascular Disease study; NHS = Nurses Health Study; PHS = Physicians Health Study; PIMA = Pima Indian study; Strong = Strong Heart Study; UK = British general practice cohort; WHS = Women’s Health Study.
